Dr Reddy’s completes Phase I study of DRL_TC, a tocilizumab biosimilar candidate
This Phase I study used an intravenous (IV) formulation to evaluate the pharmacokinetic equivalence, safety and immunogenicity of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
RoActemra
European Commission approves Actemra/RoActemra by Roche to treat severe COVID-19
Approval based on results from four phase-III studies in motre than 5,500 patients
Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial
The COVACTA study did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe…
EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source
The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19…